Chemical
Browse
Active Pharmaceutical Ingredients
Bioactive chemicals
Agrochemicals
Search
Chemical Structure
Explore
Chemical Similarity
Transformation
Browse
Prodrugs
Drug Metabolites
Metabolite Datasets
Cytochrome P450
Homo sapiens »
CYP1
CYP2
CYP3
CYP4
CYP5
CYP7
CYP8
CYP11
CYP17
CYP19
CYP20
CYP21
CYP24
CYP26
CYP27
CYP39
CYP46
CYP51
Mus musculus
Danio rerio
Oncorhynchus mykiss
Comparison of CYPs
Biochemical Action
Browse
Target Level (ChEMBL)
Level 1
Level 2
Level 3
Level 4
Level 5
Level 6
Mechanism of action
Search
Mechanism of action
BLAST against human drug target
BLAST against selected species (UniProt)
Exposure
Browse
Monitoring data
Downloads
Web services
Bulk downloads
About
About EcoDrug+
Citing
Data Sources
FAQ
Contact Us
Versions
Display Options:
Molecule Type
Mechanism of Action
Route of Adminstration
Status
Therapeutic Indication
Number of compounds:
7959
RUXOLITINIB
(2011)
Small molecule
Unknown
Unknown
Approved
Neoplasms
RUXOLITINIB
×
Maximum Phase:
4
First Approval:
2011
UNII:
82S8X8XX8H
Molecule Type:
Small molecule
Molecular Formula:
C17H18N6
Molecular Weight:
306.37
AlogP:
3.47
PSA:
83.18
HBD:
1.0
HBA:
#RotB:
4.0
Source:
IBUPROFEN SODIUM
(2012)
Small molecule
Cyclooxygenase inhibitor
ORAL
Approved
Unknown
IBUPROFEN SODIUM
×
Maximum Phase:
4
First Approval:
2012
UNII:
RM1CE97Z4N
Molecule Type:
Small molecule
Molecular Formula:
C13H21NaO4
Molecular Weight:
264.3
AlogP:
3.07
PSA:
37.3
HBD:
1.0
HBA:
#RotB:
4.0
Source:
CABOZANTINIB
(2012)
Small molecule
Unknown
Unknown
Approved
Neoplasms
CABOZANTINIB
×
Maximum Phase:
4
First Approval:
2012
UNII:
1C39JW444G
Molecule Type:
Small molecule
Molecular Formula:
C28H24FN3O5
Molecular Weight:
501.51
AlogP:
5.54
PSA:
98.78
HBD:
2.0
HBA:
#RotB:
8.0
Source:
TOFACITINIB CITRATE
(2012)
Small molecule
Janus Kinase (JAK) inhibitor
ORAL
Approved
Arthritis, Psoriatic; Arthritis, Rheumatoid
TOFACITINIB CITRATE
×
Maximum Phase:
4
First Approval:
2012
UNII:
O1FF4DIV0D
Molecule Type:
Small molecule
Molecular Formula:
C22H28N6O8
Molecular Weight:
504.5
AlogP:
1.54
PSA:
88.91
HBD:
1.0
HBA:
#RotB:
3.0
Source:
BEDAQUILINE
(2012)
Small molecule
Unknown
Unknown
Approved
Tuberculosis
BEDAQUILINE
×
Maximum Phase:
4
First Approval:
2012
UNII:
78846I289Y
Molecule Type:
Small molecule
Molecular Formula:
C32H31BrN2O2
Molecular Weight:
555.52
AlogP:
7.13
PSA:
45.59
HBD:
1.0
HBA:
#RotB:
8.0
Source:
ENZALUTAMIDE
(2012)
Small molecule
Androgen Receptor antagonist
ORAL
Approved
Neoplasms; Prostatic Neoplasms
ENZALUTAMIDE
×
Maximum Phase:
4
First Approval:
2012
UNII:
93T0T9GKNU
Molecule Type:
Small molecule
Molecular Formula:
C21H16F4N4O2S
Molecular Weight:
464.44
AlogP:
3.99
PSA:
76.44
HBD:
1.0
HBA:
#RotB:
3.0
Source:
ELVITEGRAVIR
(2012)
Small molecule
Human immunodeficiency virus type 1 integrase inhibitor
ORAL
Approved
HIV Infections; Virus Diseases
ELVITEGRAVIR
×
Maximum Phase:
4
First Approval:
2012
UNII:
4GDQ854U53
Molecule Type:
Small molecule
Molecular Formula:
C23H23ClFNO5
Molecular Weight:
447.89
AlogP:
4.28
PSA:
88.76
HBD:
2.0
HBA:
#RotB:
7.0
Source:
CYSTEAMINE HYDROCHLORIDE
(2012)
Small molecule
Cystine reducing agent
OPHTHALMIC
Approved
Cystinosis
CYSTEAMINE HYDROCHLORIDE
×
Maximum Phase:
4
First Approval:
2012
UNII:
IF1B771SVB
Molecule Type:
Small molecule
Molecular Formula:
C2H8ClNS
Molecular Weight:
113.61
AlogP:
-0.13
PSA:
26.02
HBD:
2.0
HBA:
#RotB:
1.0
Source:
PICOSULFURIC ACID
(2012)
Small molecule
Unknown
Unknown
Approved
Unknown
PICOSULFURIC ACID
×
Maximum Phase:
4
First Approval:
2012
UNII:
95D580798S
Molecule Type:
Small molecule
Molecular Formula:
C18H15NO8S2
Molecular Weight:
437.45
AlogP:
2.63
PSA:
140.09
HBD:
2.0
HBA:
#RotB:
7.0
Source:
FLORBETAPIR
(2012)
Small molecule
Unknown
Unknown
Approved
Unknown
FLORBETAPIR
×
Maximum Phase:
4
First Approval:
2012
UNII:
6867Q6IKOD
Molecule Type:
Small molecule
Molecular Formula:
C20H25FN2O3
Molecular Weight:
360.43
AlogP:
3.68
PSA:
52.61
HBD:
1.0
HBA:
#RotB:
12.0
Source:
SODIUM PICOSULFATE
(2012)
Small molecule
Stimulant laxative
Unknown
Approved
Constipation
SODIUM PICOSULFATE
×
Maximum Phase:
4
First Approval:
2012
UNII:
LR57574HN8
Molecule Type:
Small molecule
Molecular Formula:
C18H13NNa2O8S2
Molecular Weight:
481.42
AlogP:
2.63
PSA:
140.09
HBD:
2.0
HBA:
#RotB:
7.0
Source:
AXITINIB
(2012)
Small molecule
Vascular endothelial growth factor receptor inhibitor
ORAL
Approved
Carcinoma, Renal Cell; Neoplasms
AXITINIB
×
Maximum Phase:
4
First Approval:
2012
UNII:
C9LVQ0YUXG
Molecule Type:
Small molecule
Molecular Formula:
C22H18N4OS
Molecular Weight:
386.48
AlogP:
4.64
PSA:
70.67
HBD:
2.0
HBA:
#RotB:
5.0
Source:
PONATINIB
(2012)
Small molecule
Unknown
Unknown
Approved
Neoplasms
PONATINIB
×
Maximum Phase:
4
First Approval:
2012
UNII:
4340891KFS
Molecule Type:
Small molecule
Molecular Formula:
C29H27F3N6O
Molecular Weight:
532.57
AlogP:
4.46
PSA:
65.77
HBD:
1.0
HBA:
#RotB:
4.0
Source:
COBICISTAT
(2012)
Small molecule
Cytochrome P450 3A inhibitor
ORAL
Approved
HIV Infections; Infections
COBICISTAT
×
Maximum Phase:
4
First Approval:
2012
UNII:
LW2E03M5PG
Molecule Type:
Small molecule
Molecular Formula:
C40H53N7O5S2
Molecular Weight:
776.04
AlogP:
6.0
PSA:
138.02
HBD:
3.0
HBA:
#RotB:
19.0
Source:
BEDAQUILINE FUMARATE
(2012)
Small molecule
ATP synthase inhibitor
ORAL
Approved
Tuberculosis
BEDAQUILINE FUMARATE
×
Maximum Phase:
4
First Approval:
2012
UNII:
P04QX2C1A5
Molecule Type:
Small molecule
Molecular Formula:
C36H35BrN2O6
Molecular Weight:
671.59
AlogP:
7.13
PSA:
45.59
HBD:
1.0
HBA:
#RotB:
8.0
Source:
CHOLINE CHLORIDE
(2012)
Small molecule
Unknown
Unknown
Approved
Unknown
CHOLINE CHLORIDE
×
Maximum Phase:
4
First Approval:
2012
UNII:
45I14D8O27
Molecule Type:
Small molecule
Molecular Formula:
C5H14ClNO
Molecular Weight:
139.63
AlogP:
None
PSA:
None
HBD:
None
HBA:
#RotB:
None
Source:
ACLIDINIUM
(2012)
Small molecule
Unknown
Unknown
Approved
Unknown
ACLIDINIUM
×
Maximum Phase:
4
First Approval:
2012
UNII:
K17VY42F6C
Molecule Type:
Small molecule
Molecular Formula:
C26H30NO4S2+
Molecular Weight:
484.66
AlogP:
4.67
PSA:
55.76
HBD:
1.0
HBA:
#RotB:
9.0
Source:
APIXABAN
(2012)
Small molecule
Coagulation factor X inhibitor
Unknown
Approved
Atrial Fibrillation; Embolism; Pulmonary Embolism; Stroke; Thrombosis; Venous Thrombosis
APIXABAN
×
Maximum Phase:
4
First Approval:
2012
UNII:
3Z9Y7UWC1J
Molecule Type:
Small molecule
Molecular Formula:
C25H25N5O4
Molecular Weight:
459.51
AlogP:
2.7
PSA:
110.76
HBD:
1.0
HBA:
#RotB:
5.0
Source:
ICOSAPENT ETHYL
(2012)
Small molecule
Unknown
ORAL
Approved
Hypertriglyceridemia; Pancreatitis
ICOSAPENT ETHYL
×
Maximum Phase:
4
First Approval:
2012
UNII:
6GC8A4PAYH
Molecule Type:
Small molecule
Molecular Formula:
C22H34O2
Molecular Weight:
330.51
AlogP:
6.47
PSA:
26.3
HBD:
0.0
HBA:
#RotB:
14.0
Source:
ACLIDINIUM BROMIDE
(2012)
Small molecule
Muscarinic acetylcholine receptor M3 antagonist
INHALATION
Approved
Bronchial Spasm; Bronchitis, Chronic; Emphysema; Lung Diseases, Obstructive; Pulmonary Disease, Chronic Obstructive
ACLIDINIUM BROMIDE
×
Maximum Phase:
4
First Approval:
2012
UNII:
UQW7UF9N91
Molecule Type:
Small molecule
Molecular Formula:
C26H30BrNO4S2
Molecular Weight:
564.57
AlogP:
4.67
PSA:
55.76
HBD:
1.0
HBA:
#RotB:
9.0
Source:
TERIFLUNOMIDE
(2012)
Small molecule
Dihydroorotate dehydrogenase inhibitor
ORAL
Approved
Immune System Diseases; Multiple Sclerosis
TERIFLUNOMIDE
×
Maximum Phase:
4
First Approval:
2012
UNII:
1C058IKG3B
Molecule Type:
Small molecule
Molecular Formula:
C12H9F3N2O2
Molecular Weight:
270.21
AlogP:
3.0
PSA:
73.12
HBD:
2.0
HBA:
#RotB:
2.0
Source:
PONATINIB HYDROCHLORIDE
(2012)
Small molecule
Bcr/Abl fusion protein inhibitor
ORAL
Approved
Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Precursor Cell Lymphoblastic Leukemia-Lymphoma
PONATINIB HYDROCHLORIDE
×
Maximum Phase:
4
First Approval:
2012
UNII:
96R6PU3D8J
Molecule Type:
Small molecule
Molecular Formula:
C29H28ClF3N6O
Molecular Weight:
569.03
AlogP:
4.46
PSA:
65.77
HBD:
1.0
HBA:
#RotB:
4.0
Source:
CABOZANTINIB S-MALATE
(2012)
Small molecule
Hepatocyte growth factor receptor inhibitor
ORAL
Approved
Carcinoma, Renal Cell; Thyroid Neoplasms
CABOZANTINIB S-MALATE
×
Maximum Phase:
4
First Approval:
2012
UNII:
DR7ST46X58
Molecule Type:
Small molecule
Molecular Formula:
C32H30FN3O10
Molecular Weight:
635.6
AlogP:
5.54
PSA:
98.78
HBD:
2.0
HBA:
#RotB:
8.0
Source:
TOFACITINIB
(2012)
Small molecule
Unknown
ORAL
Approved
Immune System Diseases
TOFACITINIB
×
Maximum Phase:
4
First Approval:
2012
UNII:
87LA6FU830
Molecule Type:
Small molecule
Molecular Formula:
C16H20N6O
Molecular Weight:
312.38
AlogP:
1.54
PSA:
88.91
HBD:
1.0
HBA:
#RotB:
3.0
Source:
LOMITAPIDE MESYLATE
(2012)
Small molecule
Microsomal triglyceride transfer protein inhibitor
ORAL
Approved
Hypercholesterolemia; Hyperlipoproteinemia Type II
LOMITAPIDE MESYLATE
×
Maximum Phase:
4
First Approval:
2012
UNII:
X4S83CP54E
Molecule Type:
Small molecule
Molecular Formula:
C40H41F6N3O5S
Molecular Weight:
789.84
AlogP:
8.38
PSA:
61.44
HBD:
2.0
HBA:
#RotB:
10.0
Source:
TAFLUPROST
(2012)
Small molecule
Prostanoid FP receptor agonist
OPHTHALMIC
Approved
Glaucoma; Glaucoma, Open-Angle; Ocular Hypertension
TAFLUPROST
×
Maximum Phase:
4
First Approval:
2012
UNII:
1O6WQ6T7G3
Molecule Type:
Small molecule
Molecular Formula:
C25H34F2O5
Molecular Weight:
452.54
AlogP:
4.68
PSA:
75.99
HBD:
2.0
HBA:
#RotB:
12.0
Source:
PERAMPANEL
(2012)
Small molecule
Glutamate receptor ionotropic AMPA antagonist
ORAL
Approved
Epilepsy; Seizures
PERAMPANEL
×
Maximum Phase:
4
First Approval:
2012
UNII:
H821664NPK
Molecule Type:
Small molecule
Molecular Formula:
C23H15N3O
Molecular Weight:
349.39
AlogP:
4.44
PSA:
58.68
HBD:
0.0
HBA:
#RotB:
3.0
Source:
MIRABEGRON
(2012)
Small molecule
Beta-3 adrenergic receptor agonist
ORAL
Approved
Polyuria; Urinary Bladder, Overactive; Urinary Incontinence; Urinary Incontinence, Urge
MIRABEGRON
×
Maximum Phase:
4
First Approval:
2012
UNII:
MVR3JL3B2V
Molecule Type:
Small molecule
Molecular Formula:
C21H24N4O2S
Molecular Weight:
396.52
AlogP:
2.77
PSA:
100.27
HBD:
4.0
HBA:
#RotB:
9.0
Source:
IVACAFTOR
(2012)
Small molecule
Cystic fibrosis transmembrane conductance regulator positive modulator
ORAL
Approved
Cystic Fibrosis; Respiratory Tract Diseases
IVACAFTOR
×
Maximum Phase:
4
First Approval:
2012
UNII:
1Y740ILL1Z
Molecule Type:
Small molecule
Molecular Formula:
C24H28N2O3
Molecular Weight:
392.5
AlogP:
5.08
PSA:
82.19
HBD:
3.0
HBA:
#RotB:
2.0
Source:
LORCASERIN HYDROCHLORIDE
(2012)
Small molecule
Serotonin 2c (5-HT2c) receptor agonist
ORAL
Approved
Unknown
LORCASERIN HYDROCHLORIDE
×
Maximum Phase:
4
First Approval:
2012
UNII:
0QJF08GDPE
Molecule Type:
Small molecule
Molecular Formula:
C11H15Cl2N
Molecular Weight:
232.15
AlogP:
2.59
PSA:
12.03
HBD:
1.0
HBA:
#RotB:
0.0
Source:
CROFELEMER
(2012)
Small molecule
Anoctamin-1 blocker
ORAL
Approved
Unknown
CROFELEMER
×
Maximum Phase:
4
First Approval:
2012
UNII:
PY79D6C8RX
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
VISMODEGIB
(2012)
Small molecule
Smoothened homolog inhibitor
ORAL
Approved
Carcinoma, Basal Cell; Neoplasms
VISMODEGIB
×
Maximum Phase:
4
First Approval:
2012
UNII:
25X868M3DS
Molecule Type:
Small molecule
Molecular Formula:
C19H14Cl2N2O3S
Molecular Weight:
421.31
AlogP:
4.71
PSA:
76.13
HBD:
1.0
HBA:
#RotB:
4.0
Source:
CHOLINE C-11
(2012)
Small molecule
Diagnostic agent
INTRAVENOUS
Approved
Prostatic Neoplasms
CHOLINE C-11
×
Maximum Phase:
4
First Approval:
2012
UNII:
M4AS4XGD4Q
Molecule Type:
Small molecule
Molecular Formula:
C5H14ClNO
Molecular Weight:
138.63
AlogP:
None
PSA:
None
HBD:
None
HBA:
#RotB:
None
Source:
LOMITAPIDE
(2012)
Small molecule
Unknown
Unknown
Approved
Cardiovascular Diseases
LOMITAPIDE
×
Maximum Phase:
4
First Approval:
2012
UNII:
82KUB0583F
Molecule Type:
Small molecule
Molecular Formula:
C39H37F6N3O2
Molecular Weight:
693.73
AlogP:
8.38
PSA:
61.44
HBD:
2.0
HBA:
#RotB:
10.0
Source:
LORCASERIN
(2012)
Small molecule
Unknown
Unknown
Approved
Obesity
LORCASERIN
×
Maximum Phase:
4
First Approval:
2012
UNII:
637E494O0Z
Molecule Type:
Small molecule
Molecular Formula:
C11H14ClN
Molecular Weight:
195.69
AlogP:
2.59
PSA:
12.03
HBD:
1.0
HBA:
#RotB:
0.0
Source:
FLORBETAPIR F 18
(2012)
Small molecule
Diagnostic agent
Unknown
Approved
Alzheimer Disease; Cognitive Dysfunction
FLORBETAPIR F 18
×
Maximum Phase:
4
First Approval:
2012
UNII:
6W15Z5R0RU
Molecule Type:
Small molecule
Molecular Formula:
C20H25FN2O3
Molecular Weight:
359.43
AlogP:
3.68
PSA:
52.61
HBD:
1.0
HBA:
#RotB:
12.0
Source:
1
2
…
61
62
63
64
65
66
67
…
221
222
Next »
Download Option
Header
Compound Name
Maximum Phase
Compound Structure
Smile
Inchi
InchiKey
Compound Properties
Molecular Formula
Molecular Weight
ALogP
PSA